Keynote: Pharmaceutical Novel Modalities: Opportunities and Challenges

Tuesday, November 11, 2025

1:30 PM - 2:30 PM CT

Location:301 ABC

Manufacturing and Analytical Characterization

Keynote Speaker(s)

Otilia Koo, PhD, FAAPS (she/her/hers)

Portfolio Vice President
Novo Nordisk
Plainsboro, New Jersey

Moderator(s)

Carl Allenspach, PhD

Director
Bristol Myers Squibb
Bridgewater, New Jersey

This session will discuss the areas of novel manufacturing processes, cell & gene therapy, nanoparticles, delivery innovations at Novo Nordisk, and AI, modelling & simulations. There will be 1-2 opportunities and challenges discussed for each area, and these will provide insights into the trends of novel modalities in the pharmaceutical industry.

Learning Objectives:

Understand the novel areas of novel manufacturing processes, cell & gene therapy, enabling formulations, delivery innovations and AI, modelling & simulations
Insights into 1-2 opportunities and challenges in each of these 5 areas
Gain ability to apply understanding to other areas of novel modalities